Book review Young Ah Kim1,2, Hyunsoo Kim1,3, Chulhun L. Chang1,4 1Korean Society of Clinical Microbiology, 2Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, 3Department of Laboratory Medicine, National Police Hospital, Seoul, 4Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea Corresponding to Chulhun L. Chang, E-mail: cchl@pusan.ac.kr Ann Clin Microbiol 2020;23(3):159-163. https://doi.org/10.5145/ACM.2020.23.3.6Received on 27 April 2020, Revised on 19 August 2020, Accepted on 21 August 2020, Published on 20 September 2020.Copyright © Korean Society of Clinical Microbiology. Abstract The Coronavirus Disease 19 (COVID-19), which emerged as pneumonia from an unknown agent for the first time at the end of 2019, has dramatically transformed our world into one that is highly unrecognizable today. Newly emerging infectious diseases have been occurring more frequently than ever. Opportunities of such deadly microorganisms to adapt to humans—as well as spread between people on a massive scale—are growing because of active

Original article PDF Sunyoung Ahn1, Ji Yeon Sung1, Hyunsoo Kim2, Myung Sook Kim1, Younjee Hwang3, Sori Jong1, Younghee Seo1, Eunjin Ha4, Eun Suk Park4, Jun Yong Choi4,5, Dongeun Yong1,4, Kyungwon Lee1 1Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, 2Department of Laboratory Medicine, National Police Hospital, 3Brain Korea 21 PLUS Project for Medical Science, Yonsei University, 4Department of Infection Control, Severance Hospital, 5Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea Corresponding to Ji Yeon Sung, E-mail: jysung80@yuhs.ac Ann Clin Microbiol 2016;19(2):39-47. https://doi.org/10.5145/ACM.2016.19.2.39Copyright © Korean Society of Clinical Microbiology. Abstract Background: Carbapenemase-producing Enterobacteriaceae (CPE) has been increasingly reported worldwide in the past 10 years, which is an important infection control concern. Since the epidemiology and characteristics of these CPEs vary according to institutes, we aimed to characterize CPEs in a university hospital during the recent 4 years.

Original article PDF Young Ah Kim1, Yoon Soo Park2, Hyunsoo Kim3, Young Hee Seo4, Kyungwon Lee4,5 Departments of 1Laboratory Medicine, 2Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang, 3Department of Laboratory Medicine, National Police Hospital, 4Research Institute of Bacterial Resistance and 5Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea Corresponding to Yoon Soo Park, E-mail: yspark@nhimc.or.kr Ann Clin Microbiol 2018;21(2):28-35. https://doi.org/10.5145/ACM.2018.21.2.28Copyright © Korean Society of Clinical Microbiology. Abstract Background: In the present study, the prevalence and risk factors for acquisition of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in intensive care unit (ICU) settings without outbreak in the situation of widespread sequence type (ST) 131 ESBL-producing E. coli in a Korean community was investigated. Methods: Consecutive and prospective screening of ESBL-producing E. coli colonization was performed in all patients admitted to surgical or medical ICUs within 48 hours for two months. ESBL genotype was determined based on PCR and sequencing. PCR for O16-ST131/O25-ST131 was performed for all ESBL producers. Clinical

PDF Original article Annals of Clinical Microbiology (Ann Clin Microbiol) 2020 September, Volume 23, Issue 3, pages 159-163. https://doi.org/10.5145/ACM.2020.23.3.6 Young Ah Kim1,2, Hyunsoo Kim1,3, Chulhun L. Chang1,41Korean Society of Clinical Microbiology, 2Department of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, 3Department of Laboratory Medicine, National Police Hospital, Seoul, 4Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea Abstract The Coronavirus Disease 19 (COVID-19), which emerged as pneumonia from an unknown agent for the first time at the end of 2019, has dramatically transformed our world into one that is highly unrecognizable today. Newly emerging infectious diseases have been occurring more frequently than ever. Opportunities of such deadly microorganisms to adapt to humans—as well as spread between people on a massive scale—are growing because of active human mobility. We have translated and published the book, “One Health: People, Animals, and the Environment.” The original book, published in